Equities

Alphatec Holdings Inc

Alphatec Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)9.28
  • Today's Change-0.42 / -4.33%
  • Shares traded1.91m
  • 1 Year change-9.02%
  • Beta1.3577
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for surgical treatment of spine disorders. It has a range of product portfolios designed to address the spine's various pathologies. Its AIX product platform comprises of its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and Valence. The EOS imaging system is designed to provide calibrated full-body imaging that enables a three-dimensional (3D) model of patients’ skeletal systems. It has developed a patient positioning systems that integrates with its other access systems, providing for a more rigid construct and enhanced reproducibility. It offers procedure-specific access systems, including its Sigma-ALIF Access System, which allows for custom anterior abdominal exposure.

  • Revenue in USD (TTM)572.74m
  • Net income in USD-177.87m
  • Incorporated2005
  • Employees839.00
  • Location
    Alphatec Holdings Inc5818 El Camino RealCARLSBAD 92008United StatesUSA
  • Phone+1 (760) 431-9286
  • Fax+1 (302) 636-5454
  • Websitehttps://atecspine.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Castle Biosciences Inc311.88m6.08m946.09m610.00168.972.1448.453.030.19990.199911.0715.770.65629.157.15511,275.401.28-9.431.40-10.1781.9080.581.95-28.467.64--0.0228--60.3857.3514.41--117.94--
Avanos Medical Inc681.50m21.70m950.85m3.77k44.220.773214.071.400.46790.338514.7026.760.40311.905.16180,721.301.28-0.65271.45-0.733855.5154.453.18-1.601.469.840.1164---1.580.6357-146.05---18.37--
Bioventus Inc536.89m-41.96m1.01bn1.03k--6.67--1.88-0.6595-0.65958.481.860.65911.954.18553,495.90-6.70-5.52-9.65-7.2766.5368.25-10.16-10.940.9561.080.6697--0.04459.936.91--23.51--
CeriBell Inc-100.00bn-100.00bn1.03bn----------------0.5919------------------------3.53--0.4912--74.47--20.72------
Owens & Minor, Inc.10.66bn-48.79m1.03bn13.70k--1.184.650.0967-0.6346-0.6346139.2711.352.097.2615.86778,172.30-0.95611.32-1.492.0720.7216.48-0.45760.56140.45192.030.68310.7983.801.87-284.47--25.91--
Pulse Biosciences Inc0.00-46.13m1.16bn56.00--14.60-----0.8069-0.80690.001.290.00----0.00-58.03-93.21-62.84-104.99-------12,332.25----0.00---100.00--27.85---15.20--
Artivion Inc376.97m-8.32m1.21bn1.50k--4.0980.573.21-0.2076-0.20769.117.060.4811.675.44251,316.00-1.07-2.20-1.15-2.3664.6365.51-2.22-5.344.041.070.5177--12.826.14-60.09--5.13--
BioLife Solutions Inc121.17m-53.87m1.23bn409.00--3.82--10.13-1.21-1.642.696.970.29991.995.39296,254.30-13.33-13.76-14.60-15.0441.2736.76-44.46-42.991.81-5.980.0651---11.4348.6552.49--86.35--
Establishment Labs Holdings Inc151.35m-83.20m1.27bn857.00--28.11--8.36-3.11-3.115.621.610.53070.85252.72166,685.00-29.17-33.22-34.29-41.1266.0464.73-54.97-43.192.91-20.680.8114--2.1321.96-4.38--69.16--
Alphatec Holdings Inc572.74m-177.87m1.38bn839.00------2.40-1.27-1.274.080.15460.80891.117.73682,644.80-25.12-30.97-32.00-39.4769.4766.02-31.06-46.221.15-3.660.9596--37.4539.38-23.36--67.92--
Adapthealth Corp3.26bn-217.76m1.41bn10.70k--0.92728.530.431-1.64-1.6424.2311.270.709621.158.45304,912.50-4.57-4.34-5.14-4.8919.0318.28-6.44-6.470.99512.290.5757--7.73---1,169.99------
Inmode Ltd423.75m153.67m1.49bn581.0010.562.199.643.511.851.855.048.920.52391.5810.15729,339.1019.0031.3220.7735.6481.6484.4636.2639.659.91--0.000.008.3237.4922.5454.6513.10--
STAAR Surgical Co341.22m21.78m1.50bn1.06k69.433.5054.194.390.43810.43816.908.690.67632.033.15323,128.804.326.774.927.9078.7376.896.389.165.38--0.00020.0013.3721.07-46.1833.8551.95--
Myriad Genetics, Inc.823.60m-116.00m1.57bn2.70k--2.15--1.91-1.30-1.309.218.040.73859.916.84305,037.00-10.40---12.43--69.15---14.08--1.73-105.000.0506--11.03---135.09------
Evolent Health Inc2.46bn-104.23m1.76bn4.70k--1.68120.760.714-0.9129-0.912921.5510.660.953--6.14524,309.40-2.79-9.60-3.58-12.5915.9624.50-2.93-13.66---0.55950.3285--45.2625.65-660.71---6.18--
Data as of Nov 12 2024. Currency figures normalised to Alphatec Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

28.85%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20247.34m5.23%
The Vanguard Group, Inc.as of 30 Jun 20245.48m3.90%
First Light Asset Management LLCas of 30 Jun 20245.33m3.79%
American Century Investment Management, Inc.as of 30 Jun 20244.04m2.88%
JPMorgan Investment Management, Inc.as of 30 Sep 20243.54m2.52%
Millennium Management LLCas of 30 Jun 20243.40m2.42%
Point72 Asset Management LPas of 30 Jun 20243.19m2.27%
SSgA Funds Management, Inc.as of 30 Jun 20242.85m2.03%
BNP Paribas Asset Management USA, Inc.as of 30 Sep 20242.71m1.93%
Fred Alger Management LLCas of 30 Jun 20242.64m1.88%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.